Sign In | 0 items - USD $0.00 | Search | 简体中文

Products Content

Blog Tag: Parkinson's disease

N terminal acetylated alpha synuclein monomers and fibrils for neurodegenerative disease research

N-terminal Acetylated Alpha Synuclein in Parkinson’s Disease

StressMarq Biosciences | May 13th, 2021 | Scientific Review

DENND4C and the Retromer Complex in Neurodegenerative Diseases

DENND4C and the Retromer Complex in Neurodegenerative Diseases

Patricia Thomson | January 21st, 2021 | Scientific Review

Alpha synuclein SUMOylation: A Novel Therapeutic Target for Parkinson's Disease

Alpha Synuclein SUMOylation: A Novel Therapeutic Target for Parkinson’s Disease

Christina Korgiopoulou | October 2nd, 2020 |

Podcast: Gene Expression in Parkinson’s Disease with Alessia Sciortino

Patricia Thomson | September 23rd, 2020 | Podcasts

Parkinson's Disease Therapies Targeting Alpha Synuclein

Parkinson’s Disease Therapies Targeting Alpha Synuclein

Christina Korgiopoulou | September 9th, 2020 | Scientific Review

Types of Alpha Synuclein Fibrillar Constructs

Types of Alpha Synuclein Fibrillar Constructs

Christina Korgiopoulou | August 10th, 2020 | Scientific Review

Alpha synuclein oligomers and their role in synucleinopathies

Alpha Synuclein Oligomers and their Role in Synucleinopathies

Christina Korgiopoulou | July 22nd, 2020 | Scientific Review

FTY720/Fingolimod: A Potential Parkinson's Disease Treatment

FTY720/Fingolimod: A Potential Parkinson’s Disease Treatment

Christina Korgiopoulou | June 30th, 2020 | Scientific Review

Parkinson's Disease Models An Overview of Cellular Models for Neurodegeneration

Parkinson’s Disease Models: An Overview of Cellular and Animal Models for Neurodegeneration Research

Christina Korgiopoulou | January 29th, 2020 | Scientific Review

Alpha Synuclein in Parkinson's Disease

Alpha Synuclein in Parkinson’s Disease

Christina Korgiopoulou | January 22nd, 2020 | Scientific Review